C12R 2001/47
Streptomyces albus
C12R2001/47 (Streptomyces albus) appears on 12 US grants and 5 published applications in this corpus.
Search patents in C12R- Granted patents
- 12
- Published applications
- 5
- Assignees
- 10
- Inventors
- 34
- Latest grant
- 20 Apr 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Genetically modified host organism for expressing an anthracyclinone analogue, method associated therewith, and synthetic nucleic acids20 Apr 2021US 10,980,817 B2
- Process and microorganisms for production of lipids from lignocellulosic wastes or residues15 Apr 2014US 8,697,403 B2Neste Oil Oyj
- Micro-organisms for the treatment of soil and process for obtaining them30 Nov 2010US 7,842,494 B2Agro.Bio Hungary KFT.
- Enkastins: new glycopeptides which act to inhibit enkephlinase, processes for their preparation, and their use as pharmaceutical products12 Apr 1994US 5,302,582 AHoechst Aktiengesellschaft
- BMY-28121, a new antitumor antibiotic19 Jun 1990US 4,935,362 ABristol-Myers Company
- Hexadepsipeptide compounds and methods of using the same2 May 2024US 2024/0140992 A1Lodo Therapeutics Corporation
- Method for improving production of streptomyces polyketide compounds23 Feb 2023US 2023/0056311 A1East China University of Science and Technology
- Genetically modified host organism for expressing an anthracyclinone analogue, method associated therewith, and synthetic nucleic acids27 Dec 2018US 2018/0369256 A1
- Process and Microorganisms for Production of Lipids1 Dec 2011US 2011/0294173 A1Neste Oil Oyj
- Micro-organisms for the treatment of soil and process for obtaining them24 Mar 2005US 2005/0060930 A1Agro.Bio Hungary KFT.
Most cited
By later US patents
- Deoxy-(0-8)-epi-17-salinomycin (1)9US 4,137,241 AHoffmann-La Roche Inc. · 1979
- BMY-28121, a new antitumor antibiotic9US 4,683,230 ABristol-Myers Company · 1987
- BMY-28121, a new antitumor antibiotic8US 4,935,362 ABristol-Myers Company · 1990
- Antibiotic A-328875US 4,132,778 AEli Lilly and Company · 1979
- Enkastins: new glycopeptides which act to inhibit enkephlinase, processes for their preparation, and their use as pharmaceutical products4US 5,302,582 AHoechst Aktiengesellschaft · 1994